|
RAVER2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.413800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.262500E-03 |
| Normal-vs-Stage2 |
7.306200E-01 |
| Normal-vs-Stage3 |
1.118200E-01 |
| Normal-vs-Stage4 |
1.610470E-02 |
| Stage1-vs-Stage2 |
2.173600E-02 |
| Stage1-vs-Stage3 |
2.16069999999791E-05 |
| Stage1-vs-Stage4 |
1.99280000001689E-06 |
| Stage2-vs-Stage3 |
4.141200E-01 |
| Stage2-vs-Stage4 |
1.347980E-01 |
| Stage3-vs-Stage4 |
4.036800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.030000E-01 |
| Normal-vs-AfricanAmerican |
3.089600E-01 |
| Normal-vs-Asian |
4.609400E-01 |
| Caucasian-vs-AfricanAmerican |
1.741170E-01 |
| Caucasian-vs-Asian |
4.254800E-01 |
| AfricanAmerican-vs-Asian |
1.605770E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.884200E-01 |
| Normal-vs-Female |
2.086000E-02 |
| Male-vs-Female |
1.363870E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.632800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.398200E-01 |
| Normal-vs-Age(61-80Yrs) |
5.933800E-01 |
| Normal-vs-Age(81-100Yrs) |
5.629200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.280000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.809600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.150800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.677600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.990000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.070600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.618200E-03 |
| Normal-vs-Grade 2 |
2.193300E-04 |
| Normal-vs-Grade 3 |
3.459200E-01 |
| Normal-vs-Grade 4 |
2.30940000456314E-08 |
| Grade 1-vs-Grade 2 |
1.578240E-01 |
| Grade 1-vs-Grade 3 |
3.608700E-04 |
| Grade 1-vs-Grade 4 |
2.10259998301154E-09 |
| Grade 2-vs-Grade 3 |
5.4767000001732E-07 |
| Grade 2-vs-Grade 4 |
<1E-12 |
| Grade 3-vs-Grade 4 |
2.14339999971003E-07 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.83729997882409E-09 |
| Normal-vs-ccB subtype |
2.0817999999978E-05 |
| ccA subtype-vs-ccB subtype |
1.62458935193399E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.458400E-01 |
| Normal-vs-N1 |
3.181000E-03 |
| N0-vs-N1 |
4.038000E-02 |
|
|
